Efficacy of Tacrine as a Nerve Agent Pretreatment

References

• Albert A., Gledhil W. Improved synthesis of aminoacridines. IV. Substituted 9-aminoacridines. J. Soc. Chem. Ind. (1945); 64: 169
   Google Scholar
• Heilbronn E. Inhibition of cholinesterases by tetrahydro-aminoacridine. Acta Chem. Scand. (1961); 15: 1386
   Google Scholar
• Shaw F. H., Bendy G. A. The pharmacology of some new anticholinesterases. Aust. J. Exp. Biol. Med. Sci. (1953); 31: 573
   PubMedGoogle Scholar
• Shaw F. H., Bently G. A. Morphine antagonism. Aust. J. Exp. Biol. Med. Sci. (1955); 33: 143
   PubMedGoogle Scholar
• Kaul P. N. Enzyme inhibition by tetrahydroaminoacridine. J. Pharm. Pharmacol. (1962); 14: 243
   PubMed Web of Science ®Google Scholar
• Summers W. K., Kaufman K. R., Altman F., Jr., Fisher J. M. THA: A review of the literature and its use in treatment of five overdose patients. Clin. Toxicol. (1980); 16: 268
   Google Scholar
• Giacobini E., Becker R. “Current Research in Alzheimer Therapy”. Taylor and Francis, New York 1988
   Google Scholar
• Summers W. K., Majovski L. V., Marsh G. M., Tachiki K., Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. (1986); 315: 1241
   PubMed Web of Science ®Google Scholar
• Amshey J. W., Steinberg G. M., Miller R. B. A screening program for selective inhibitors of the phosphorylation of acetylcholinesterase. Department of the Army, Aberdeen Proving Ground, MD (1973), Edgewood Arsenal Technical Report, EB-TR-73014
   Google Scholar
• Bajgar J, Potocka J, Fusek J., Hrdina V. Some possibilities of protection against acetylcholinesterase inhibition by organophosphates in vivo. Sb. Ved. Pr. Lek Fak Univ. Karlovy Hradci Kralove (1984); 27: 425
   PubMedGoogle Scholar
• Galli A, Mori F. Effectiveness of l,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication. Arch. Toxicol. (1991); 65: 330
   PubMed Web of Science ®Google Scholar
• De La Hoz D., Doctor B, Rolston J. S., Rush R. S, Wolfe A D. A simplified procedure for the purification of large quantities of fetal bovine serum acetylcholinesterase. Life Sci. (1986); 39: 195
   PubMed Web of Science ®Google Scholar
• Ellman G. L, Courtney K. D., Andres V., Jr., Featherstone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharm. (1961); 7: 88
   PubMed Web of Science ®Google Scholar
• Keijer J H, Wolring G. Z., DeJong LP. A. Effect of pH, temperature and ionic strength on the aging of phosphonylated cholinesterases. Biochem. Biophys. Acta (1974); 334: 146
   Web of Science ®Google Scholar
• Finney D J. Probit Analysis. Cambridge University Press, Cambridge 1971
   Google Scholar
• Bliss C. I. Fisher's Exact Test for 2 x 2 Tables. “Statistics in Biology”. McGraw-Hill, New York (1967); Vol I: 63
   Google Scholar
• Sanberg P R, Hagenmeyer S. H.M., Henault A. Automated measurement of multivariant locomotor behavior in rodents. Neurobehav. Tox. Teratol. (1985); 7: 87
   PubMedGoogle Scholar
• Number Cruncher Statistical System. J.L. Hintze, Kaysville, UT (1987), version 5.01
   Google Scholar
• Kuribara H, Haraguchi H., Tadokoro S. Comparison between discrete lever press and shuttle avoidance responses in mice: Acquisition process and psychoactive drugs. Jap. J. Pharmacol. (1985); 38: 141
   PubMedGoogle Scholar
• Romano J. A, Mterry R., MMurrow L., Mays M. Z. Protection from lethality and behavioral incapacitation resulting from intoxication by soman (pinacolyl methylphosphono fluoridate) and treatment with atropine sulfate and 2-PAM chloride in the guinea pig, caviaprocellus. Drug Chem. Tox. (1991); 14: 21
   PubMed Web of Science ®Google Scholar
• Nielsen A. J, Mena E. E, Williams I. H., Noccerini M R, Liston D. Correlation of brain levels of 9-amino-l,2,3,4-tetrahydroacridine in vitro. Eur. J. Pharmacol. (1989); 173: 53
   PubMed Web of Science ®Google Scholar
• Natori K., Okazaki Y., Irie T., Katstube J. Pharmacological and biochemical assessment of SM-10888, a novel cholinesterase inhibitor. Jap. J. Pharmac (1990); 53: 145
   PubMedGoogle Scholar
• Hunter A. J., Murray T. K., Jones J. A., Cross A. J., Green A. R. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro. Br. J. Pharmacol. (1989); 98: 79
   PubMed Web of Science ®Google Scholar
• Marquis J. K. Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine. Biochem. Pharm. (1990); 40: 1071
   PubMed Web of Science ®Google Scholar
• Patoč ka J., Bajgar J., Bielavsky J., Fusek J. Kinetics of inhibition of cholinesterases by 1,2,3,4-tetrahydroaminoacridine in vitro. Coll. Czech. Chem. Commun. (1976); 41: 816
   Google Scholar
• Dawson R. M. Reversibility of the inhibition of acetylcholinesterase by tacrine. Neurosci. Letters (1990); 118: 85
   PubMed Web of Science ®Google Scholar
• Potoč ka J., Bajgar J. The reactivation of o-isoproplymethyl-phosphonylated acetylcholinesterase and its modification by some non-acylating ligands. Sb. Ved. Pr. Lek. Fak. Univ. Karlovy Hradci Kralove (1984); 27: 477
   PubMedGoogle Scholar
• Wu C. S., Yang J. T. Tacrine protection of acetylcholinesterase form inactivation by diisopropylfluorophosphate: A circular dichroism study. Mol. Pharmacol. (1989); 35: 85
   PubMed Web of Science ®Google Scholar
• Steinberg G. M., Mednick M. L., Maddox J., Rice R., Cramer J. A hydrophobic binding site in acetylcholinesterase. J. Med. Chem. (1975); 18: 1056
   Web of Science ®Google Scholar
• Freeman S. E., Dawson R. M. Tacrine: A pharmacological review. Prog. Neurobiol. (1991); 36: 257
   PubMed Web of Science ®Google Scholar
• Dawson R. M. Tacrine slows the rate of ageing of sarin-inhibited acetylcholinesterase. Neurosci. Letters (1989); 100: 227
   PubMed Web of Science ®Google Scholar
• Deyi X., Linxiu W., Shuqiu P. The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against soman poisoning in vivo. Fundam. Appl. Toxicol. (1981); 1: 217
   PubMedGoogle Scholar
• Departments of the Army, the Navy, and the Air Force. “Treatment of Chemical Agent Casualties and Conventional Military Chemical Injuries”. U.S. Government Printing Office, Washington, DC (1990), Army FM 8–285
   Google Scholar